skyebiologics.comSkye Biologics - Overview News & Competitors ZoomInfocom

Home Technology Platform Technology Novel Manufacturing Process Products All Products ActiveBarrier® ActiveMatrix® CryoMatrix® BioRenew® PTM Therapy® ReVive® Membrane ReVive® Flow WoundEx® BurnMatrix® OculoMatrix® & VisiDisc® Orthobiologics Resources Published Studies White Papers Instructions for Use Certificates Technique Guides Product Indications Physicians Distributors Opportunities Sign In About Our Purpose News & Events Contact Home Technology Platform Technology Novel Manufacturing Process Products All Products ActiveBarrier® ActiveMatrix® CryoMatrix® BioRenew® PTM Therapy® ReVive® Membrane ReVive® Flow WoundEx® BurnMatrix® OculoMatrix® & VisiDisc® Orthobiologics Resources Published Studies White Papers Instructions for Use Certificates Technique Guides Product Indications Physicians Distributors Opportunities Sign In About Our Purpose News & Events Contact explore current commercial tissue products Advancing the frontier of biologic therapies is relentlessly committed to maximizing the therapeutic potential by unmapping human biology to treat patients suffering from degenerative disease, damaged tissue, injury, and trauma. As one ages, the body’s ability to repair and remodel decreases. Employing innovative science, Skye is discovering and developing breakthrough therapeutics that optimize the repair process and lead to organized scar free advanced healing. Our novel approach begins with a platform of naturally advanced human biological material from which we unravel the code of complex molecules, isolating and applying them to treat a multitude of conditions. Targeted therapies under development have the power to help upwards of 50 million patients per year. Future Biologics Addressing a $100 billion market, Skye is rapidly advancing multiple future regenerative biological therapies that will target all areas of the musculoskeletal system, internal tissue structures and areas where there is a high-unmet medical need and leverages its platform and expertise. We are dedicated and strive to accelerate to market regenerative solutions that improve health outcomes and dramatically improve people's lives. A biotech leader since 2005, Skye has grown to be one of the world's leading independent new age biotechnology companies, has reached hundreds of thousands of patients in the US with existing tissue products and is developing a pipeline of medicines with breakaway potential for decades to come. Active & Future Clinical Trials Orthopedic / Sports Medicine / Spine / Foot & Ankle / Wounds / Urology & GYN Back to Top © Copyright Inc. 2020...